Interview with Dr. Sylvia Adams on Possible Triple Negative Treatment

Developments In the Treatment of Metastatic Triple Negative Breast Cancer with Dr Sylvia AdamsПодробнее

Dr. Sylvia Adams: Discussing prevention of metastasis in women with early breast cancer - part 2Подробнее

Dr. Adams on Combinatorial Approaches in Triple-Negative Breast CancerПодробнее

Copy of Dr. Adams on Immunotherapy in Triple-Negative Breast CancerПодробнее

Dr. Adams on Whether Prior Lines of Therapy Impact Response to Immunotherapy in TNBCПодробнее

Interview dr. Sylvia Adams, SABC 2013Подробнее

Dr. Sylvia Adams on Tumor-Infiltrating Lymphocytes in Triple Negative Breast CancerПодробнее

Dr. Adams on Immunotherapy in Triple-Negative Breast CancerПодробнее

Breast Cancer Immunotherapy with Dr. Sylvia Adams and Victor Ty, BSN, RNПодробнее

Comment: Metastatic triple-negative breast cancer responds to immunotherapyПодробнее

Dr. Linda Vahdat on Glembatumumab Vedotin as a Treatment in Triple Negative Breast CancerПодробнее

Optimizing Immunotherapy for the Treatment of Metastatic, Triple Negative Breast CancerПодробнее

Combination Immunotherapy Appears Promising in Breast Cancer SubtypesПодробнее

Copy of Dr. Adams on Whether Prior Lines of Therapy Impact Response to Immunotherapy in TNBCПодробнее

Dr. Sylvia Adams: Discussing prevention of metastasis in women with early breast cancer - part 1Подробнее

Hitting triple-negative breast cancer where it hurts: FUTURE MagazineПодробнее

An Expert Explains the Three Major Treatment Modalities in Triple Negative Breast CancerПодробнее

Dr. Adams on the Utility of Combination CTLA-4 and PD-1 Blockade in Breast CancerПодробнее

Phase II Results for Pembrolizumab Monotherapy in Metastatic TNBCПодробнее